{"date":"2026-06-17","count":51,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7881-2026-06-17-2151-1k3j3d7","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"21:51:16","subject":"更正本公司114年第4季合併及個體財務報告附註部份內容，本次更正對財報損益並無影響","clause":"第44款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-06-17 21:51，「更正本公司114年第4季合併及個體財務報告附註部份內容，本次更正對財報損益並無影響」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-06-17-1837-fyx5vc","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"18:37:53","subject":"本公司受邀參加華南永昌證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-06-18","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-06-17 18:37，「本公司受邀參加華南永昌證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-17-1814-1mve6xu","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:14:36","subject":"公告本公司董事會通過委任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-17 18:14，「公告本公司董事會通過委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-17-1814-s0kpz3","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:14:05","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-17 18:14，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-17-1813-isqttc","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:13:31","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-17 18:13，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-17-1812-tbn9ja","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:12:58","subject":"公告本公司115年股東常會通過解除新任董事競業限制","clause":"第21款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-17 18:12，「公告本公司115年股東常會通過解除新任董事競業限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-17-1812-1udd9xf","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:12:18","subject":"公告本公司新任法人董事指派代表人","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-17 18:12，「公告本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-17-1811-13sk2v0","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:11:41","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-17 18:11，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-17-1811-1hvkc3c","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:11:03","subject":"公告本公司115年股東常會全面改選董事","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-17 18:11，「公告本公司115年股東常會全面改選董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-06-17-1810-1jb8ii5","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:10:21","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-06-17 18:10，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-06-17-1810-xev7kf","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-06-17","time":"18:10:19","subject":"公告本公司取得會計師114年內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-06-17 18:10，「公告本公司取得會計師114年內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-06-17-1800-1tprx43","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"18:00:00","subject":"公告本公司第四屆薪酬委員會委員","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-06-17 18:00，「公告本公司第四屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-06-17-1759-1r2d1uw","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:59:19","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-06-17 17:59，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-06-17-1748-dbmzf","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:48:51","subject":"公告本公司115年股東會決議解除董事競業禁止之限制","clause":"第21款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-06-17 17:48，「公告本公司115年股東會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-06-17-1748-svc53o","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:48:43","subject":"公告本公司將召開投資人可參與之重大訊息記者會","clause":"第53款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-06-17 17:48，「公告本公司將召開投資人可參與之重大訊息記者會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-06-17-1748-1jb8ii5","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:48:06","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-06-17 17:48，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2026-06-17-1747-j6c913","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:47:20","subject":"本公司因有重大訊息待公布，經櫃買中心同意自115年6月18日起暫停交易","clause":"第40款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2026-06-17 17:47，「本公司因有重大訊息待公布，經櫃買中心同意自115年6月18日起暫停交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-06-17-1743-xmx23a","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:43:46","subject":"公告本公司115年股東常會改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-06-17 17:43，「公告本公司115年股東常會改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-06-17-1738-9769qc","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:38:33","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-06-17 17:38，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4120-2026-06-17-1730-57ptxq","company_id":"4120","company":"友華","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:30:12","subject":"代子公司友杏生技醫藥(股)公司公告一一五年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：友華（4120），2026-06-17 17:30，「代子公司友杏生技醫藥(股)公司公告一一五年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-06-17-1727-1m9yg14","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:27:39","subject":"公告本公司審計委員會成員異動","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-06-17 17:27，「公告本公司審計委員會成員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-06-17-1727-18l65rv","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:27:01","subject":"公告本公司股東常會通過解除董事競業禁止案","clause":"第21款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-06-17 17:27，「公告本公司股東常會通過解除董事競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-06-17-1726-8tyjam","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:26:23","subject":"公告本公司115年06月17日股東常會獨立董事補選當選名單","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-06-17 17:26，「公告本公司115年06月17日股東常會獨立董事補選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-06-17-1718-1roellr","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-06-17","time":"17:18:08","subject":"公告本公司董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-06-17 17:18，「公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2026-06-17-1716-1jb8ii5","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:16:51","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2026-06-17 17:16，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-06-17-1714-u8k4g8","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"17:14:33","subject":"代子公司謙曜資本股份有限公司公告投資私募基金案","clause":"第24款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-06-17 17:14，「代子公司謙曜資本股份有限公司公告投資私募基金案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-06-17-1648-5rax5d","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:48:19","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-06-17 16:48，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-06-17-1646-1rxywbt","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:46:55","subject":"公告本公司新任永續長","clause":"第11款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-06-17 16:46，「公告本公司新任永續長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-06-17-1645-vbz94h","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:45:46","subject":"公告本公司董事會通過成立永續發展委員會及委任永續發展委員會委員","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-06-17 16:45，「公告本公司董事會通過成立永續發展委員會及委任永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-06-17-1636-txcsca","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"16:36:47","subject":"補充公告本公司115年股東常會全面改選董事及獨立董事當選名單(新任法人董事指派代表人)","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-06-17 16:36，「補充公告本公司115年股東常會全面改選董事及獨立董事當選名單(新任法人董事指派代表人)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-06-17-1634-1ubmbbb","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-06-17","time":"16:34:57","subject":"代重要子公司美國永生公告董事會決議辦理現金增資","clause":"第11款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-06-17 16:34，「代重要子公司美國永生公告董事會決議辦理現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-06-17-1632-wh0hc7","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-06-17","time":"16:32:03","subject":"公告本公司中華民國境內第三次無擔保轉換公司債修正為中華民國境內第三次有擔保轉換公司債暨其發行及轉換辦法修訂","clause":"第51款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-06-17 16:32，「公告本公司中華民國境內第三次無擔保轉換公司債修正為中華民國境內第三次有擔保轉換公司債暨其發行及轉換辦法修訂」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-06-17-1614-8o380u","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"16:14:38","subject":"公告本公司董事會通過委任第六屆薪資報酬委員會委員名單","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-06-17 16:14，「公告本公司董事會通過委任第六屆薪資報酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-06-17-1613-qakovl","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"16:13:14","subject":"公告本公司董事會通過張漢東先生續任董事長","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-06-17 16:13，「公告本公司董事會通過張漢東先生續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-06-17-1612-1q83wxo","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"16:12:05","subject":"公告本公司一一五年股東常會通過解除董事競業禁止之限制","clause":"第21款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-06-17 16:12，「公告本公司一一五年股東常會通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-06-17-1610-8ysypv","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"16:10:17","subject":"公告本公司第三屆審計委員會委員名單","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-06-17 16:10，「公告本公司第三屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-06-17-1609-owtts6","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:09:24","subject":"公告本公司115年股東常會通過解除新任董事競業禁止之限制","clause":"第22款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-06-17 16:09，「公告本公司115年股東常會通過解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-06-17-1609-geom9d","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"16:09:06","subject":"公告本公司一一五年股東常會選舉第七屆董事當選名單","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-06-17 16:09，「公告本公司一一五年股東常會選舉第七屆董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-06-17-1608-1vb8x25","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:08:44","subject":"公告本公司委任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-06-17 16:08，「公告本公司委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-06-17-1608-13sk2v0","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:08:20","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-06-17 16:08，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-06-17-1607-1n1y3kt","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:07:41","subject":"公告本公司董事長續任","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-06-17 16:07，「公告本公司董事長續任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-06-17-1607-1sm4cuz","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:07:12","subject":"公告本公司115年股東常會董事改選當選名單","clause":"第6款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-06-17 16:07，「公告本公司115年股東常會董事改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-06-17-1606-1jb8ii5","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"16:06:16","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-06-17 16:06，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-06-17-1606-1jb8ii5","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"16:06:10","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-06-17 16:06，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-06-17-1509-4yzujo","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"15:09:58","subject":"公告本公司訂定除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-06-17 15:09，「公告本公司訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-06-17-1508-1dk0sd9","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"15:08:56","subject":"公告本公司115年股東常會通過解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-06-17 15:08，「公告本公司115年股東常會通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-06-17-1508-1jb8ii5","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"15:08:09","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-06-17 15:08，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2026-06-17-1459-1bkm0mx","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2026-06-17","time":"14:59:33","subject":"公告本公司代理發言人異動","clause":"第8款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2026-06-17 14:59，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-06-17-1433-ag0ktz","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-06-17","time":"14:33:50","subject":"本公司受邀參加永豐金證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-06-23","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-06-17 14:33，「本公司受邀參加永豐金證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-06-17-1406-1jb8ii5","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-06-17","time":"14:06:17","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-17","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-06-17 14:06，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-06-17-1405-l9rdsv","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-06-17","time":"14:05:16","subject":"有關檢調單位至本公司進行調查說明","clause":"第19款","fact_date":"2026-06-16","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-06-17 14:05，「有關檢調單位至本公司進行調查說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}